Morepen Laboratories Limited (MOREPENLAB.NS)
INR 49.24
(3.08%)
INR 49.24
(3.08%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 12.93 Billion INR | 16.45% |
| 2022 | 11.1 Billion INR | 3.78% |
| 2021 | 10.7 Billion INR | 24.69% |
| 2020 | 8.58 Billion INR | 29.34% |
| 2019 | 6.63 Billion INR | 7.85% |
| 2018 | 6.15 Billion INR | 5.01% |
| 2017 | 5.85 Billion INR | 8.82% |
| 2016 | 5.38 Billion INR | 2.79% |
| 2015 | 5.23 Billion INR | 7.09% |
| 2014 | 4.89 Billion INR | -0.1% |
| 2013 | 4.89 Billion INR | -3.28% |
| 2012 | 5.06 Billion INR | -7.48% |
| 2011 | 5.46 Billion INR | -20.75% |
| 2010 | 6.9 Billion INR | 1.89% |
| 2009 | 6.77 Billion INR | -4.94% |
| 2008 | 7.12 Billion INR | -38.66% |
| 2007 | 11.61 Billion INR | -4.12% |
| 2006 | 12.11 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 12.93 Billion INR | 16.45% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 11.93 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 12.93 Billion INR | 0.0% |
| 2022 Q2 | 10.52 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 11.1 Billion INR | 0.0% |
| 2022 FY | 11.1 Billion INR | 3.78% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 10.7 Billion INR | 24.69% |
| 2021 Q4 | 10.7 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 10.37 Billion INR | 0.0% |
| 2020 Q2 | 7.86 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 8.58 Billion INR | 0.0% |
| 2020 FY | 8.58 Billion INR | 29.34% |
| 2020 Q1 | - INR | -100.0% |
| 2019 FY | 6.63 Billion INR | 7.85% |
| 2019 Q4 | 6.63 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 6.86 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 FY | 6.15 Billion INR | 5.01% |
| 2018 Q2 | 5.97 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 6.15 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 FY | 5.85 Billion INR | 8.82% |
| 2017 Q4 | 5.85 Billion INR | 0.0% |
| 2016 FY | 5.38 Billion INR | 2.79% |
| 2015 FY | 5.23 Billion INR | 7.09% |
| 2014 FY | 4.89 Billion INR | -0.1% |
| 2013 FY | 4.89 Billion INR | -3.28% |
| 2012 FY | 5.06 Billion INR | -7.48% |
| 2011 FY | 5.46 Billion INR | -20.75% |
| 2010 FY | 6.9 Billion INR | 1.89% |
| 2009 FY | 6.77 Billion INR | -4.94% |
| 2008 FY | 7.12 Billion INR | -38.66% |
| 2007 FY | 11.61 Billion INR | -4.12% |
| 2006 FY | 12.11 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | 46.833% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 49.917% |
| Albert David Limited | 4.97 Billion INR | -159.684% |
| Alembic Limited | 23.28 Billion INR | 44.468% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -2646.667% |
| Hester Biosciences Limited | 6.62 Billion INR | -95.246% |
| Hikal Limited | 24.87 Billion INR | 48.004% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -10.995% |
| Ind-Swift Limited | 6.54 Billion INR | -97.595% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 42.381% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -438.697% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -84.667% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -287.856% |
| Medico Remedies Limited | 961.95 Million INR | -1244.354% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -62.798% |
| RPG Life Sciences Limited | 5.12 Billion INR | -152.151% |
| Sigachi Industries Limited | 6.94 Billion INR | -86.299% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 98.487% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 42.628% |
| Themis Medicare Limited | 5.66 Billion INR | -128.313% |
| Unichem Laboratories Limited | 31.69 Billion INR | 59.196% |
| Vaishali Pharma Limited | 799.55 Million INR | -1517.402% |
| Venus Remedies Limited | 6.26 Billion INR | -106.309% |
| Windlas Biotech Limited | 6.26 Billion INR | -106.514% |
| ZIM Laboratories Limited | 4.46 Billion INR | -189.423% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 79.937% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -775.671% |
| FDC Limited | 24.68 Billion INR | 47.603% |
| Gufic Biosciences Limited | 10.92 Billion INR | -18.367% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 88.802% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 40.978% |
| Orchid Pharma Limited | 15.53 Billion INR | 16.775% |
| Alkem Laboratories Limited | 155.74 Billion INR | 91.697% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -69.018% |
| Brooks Laboratories Limited | 904.45 Million INR | -1329.819% |
| Eris Lifesciences Limited | 70.48 Billion INR | 81.654% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 54.631% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 44.89% |
| Innova Captab Limited | 13.2 Billion INR | 2.095% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -495.733% |
| Wanbury Limited | 3.43 Billion INR | -276.486% |
| Lupin Limited | 239.97 Billion INR | 94.611% |
| Sakar Healthcare Limited | 3.88 Billion INR | -232.735% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 97.131% |
| Divi's Laboratories Limited | 154.7 Billion INR | 91.641% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -19.96% |
| Mankind Pharma Limited | 119.63 Billion INR | 89.19% |
| Sequent Scientific Limited | 15.4 Billion INR | 16.047% |
| Laurus Labs Limited | 83.87 Billion INR | 84.581% |
| Neuland Laboratories Limited | 18.32 Billion INR | 29.432% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 67.622% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 90.994% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 95.583% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -252.496% |
| Wockhardt Limited | 76.49 Billion INR | 83.093% |
| Bal Pharma Limited | 3.2 Billion INR | -303.636% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 96.663% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -6.536% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -1172.701% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 52.057% |
| Shilpa Medicare Limited | 30.93 Billion INR | 58.192% |
| Valiant Laboratories Limited | 3.42 Billion INR | -277.372% |
| Ajanta Pharma Limited | 46.38 Billion INR | 72.12% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -324.013% |
| Granules India Limited | 55.2 Billion INR | 76.577% |
| Medicamen Biotech Limited | 2.94 Billion INR | -339.085% |
| Ipca Laboratories Limited | 111.01 Billion INR | 88.351% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -219.575% |
| Piramal Enterprises Limited | 826.05 Billion INR | 98.434% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 91.414% |
| NATCO Pharma Limited | 69.06 Billion INR | 81.275% |
| Suven Life Sciences Limited | 2.84 Billion INR | -353.911% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -625.807% |
| Strides Pharma Science Limited | 58.39 Billion INR | 77.855% |
| Indoco Remedies Limited | 21.44 Billion INR | 39.703% |
| Alpa Laboratories Limited | 1.82 Billion INR | -608.133% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -757.173% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -151.088% |